Introduction {#Sec1}
============

In 2008, there were 12,250 new cases of laryngeal cancer in USA \[[@CR1]\], and a significant proportion of these will ultimately require laryngectomy for treatment of primary or recurrent disease. In addition, there is a smaller, but severely impaired group of patients with non-functioning larynges due to benign disease and trauma \[[@CR2]\]. Recent chemoradiation protocols have coincided with modest survival gains for advanced laryngeal cancer, although sometimes at the expense of function; laryngectomy remains a mainstay of treatment. Despite our recent success in clinical airway tissue engineering \[[@CR3]\], there is no practical way of substituting the complex functions of the larynx using free tissue transfer, prosthetics or present regenerative medicine techniques. Hence, laryngeal transplantation remains an attractive solution to the considerable quality-of-life impairment faced by laryngectomees \[[@CR4], [@CR5]\].

The viability of laryngeal transplantation was confirmed by the single well-documented human laryngeal transplant recipient \[[@CR6], [@CR7]\] who continues to thrive a decade after transplantation with excellent speech and normal swallowing \[[@CR7]\]. There is also a report of successes with tracheal transplantation in Colombian patients \[[@CR8]\]. These cases demonstrate what may be possible for such patients, but the lack of detailed information on any other than the 1998 patient indicates that more pre-clinical work is needed before laryngeal transplant is a realistic option for most patients.

In two studies of patients' views, the main concern was the level of immunosuppression required by transplant recipients, especially important as the target population includes those with cancer \[[@CR9], [@CR10]\]. However, most people would accept a moderate level of risk in return for substantial gains in quality of life \[[@CR10]\]. Before examining the immunological response to grafting, it is essential to measure the response of grafts to ischemia and reperfusion, as well as to determine the functional results of laryngeal transplantation \[[@CR11]\]. If we want to separate these responses from those involved in tissue rejection this needs to be done using MHC-matched donors and recipients.

Previous work with dogs and rats permitted major progress, but also had limitations \[[@CR12]--[@CR15]\]. There is a limited range of immunological probes available for studying mucosal responses in dogs. Rats require buried, heterotopic grafts which make repeated observations and functional assessments impossible \[[@CR14]\]. Pigs have genetically well-defined strains with a choice of SLA antigen expression ideal for transplant studies \[[@CR16]\], and also have well-described neuromuscular \[[@CR17], [@CR18]\] and mucosal immune anatomy \[[@CR19]\].We developed an orthotopic laryngeal transplantation in NIH minipigs \[[@CR20]\] which mirrored the clinical setting \[[@CR6]\] and have previously reported results from the first 8 h after revascularisation of donor larynges in recipient pigs \[[@CR20]\]. The present paper is a logical extension of our previous work \[[@CR18], [@CR20]\] and is based on the consensus findings of the World's first symposium on this subject \[[@CR11]\].

We aimed to measure the response to transplantation at 1 week. One week is a key milestone as it is the point of functional rehabilitation for human laryngectomees: the point at which sufficient healing of the pharyngeal anastomosis has occurred to permit swallowing and speech rehabilitation commences. A study of pharygeosophageal reconstruction after total larygopharyngectomy\[[@CR21]\] found that, on average, patients needed 1.1 days ventilator support and left hospital after 4.7 days. In the 1998 transplant \[[@CR6]\] the patient had some speech after 1 week.

This study also permitted the training of a group of clinicians in techniques, including post-operative care and monitoring which will be relevant to planned clinical trials. Here, we present functional, vascular and myologic observations at 48 h and 1 week after transplantation at which time points we expected to see immune responses to ischaemia--reperfusion injury and to the onset of rejection, respectively \[[@CR22]\]. The immunological response of the laryngeal mucosa to transplantation is reported separately.

Materials and methods {#Sec2}
=====================

Animals {#Sec3}
-------

About 34 *cc* NIH minipigs (median 17 kg, range 26--48; IAH, Berkshire, UK) were kept under conditions determined by local and national ethical guidelines. Transplants were female-into-female/female-into-male to avoid a host immune response to Y-chromosome-related antigens. Two weeks' acclimatisation before intervention was included to overcome the observed stress responses in pigs that occur following transportation.

Three days before transplantation a percutaneous endoscopic gastrostomy (PEG, Direct Medical Supplies Ltd, Alton, UK) and femoral dual lumen central line (Vygon, Gloucester, UK) were inserted under general anaesthesia.

Initially, open gastrostomies at the time of surgery were planned to permit feeding whilst protecting a healing pharyngeal anastomosis. However, we found in preliminary studies that the tube could become blocked by consumed substances in the animal stomach and that the abdominal surgery appeared to cause the animals distress. Placement of a PEG 3 days prior to surgery reduced the surgical trauma and permitted pigs to become accustomed to the presence and use of a tube in advance of post-operative care.

Likewise, we found that intravenous catheters and arterial lines placed in the ear or leg were poorly tolerated for more than short periods of time and were difficult and distressing to replace. Therefore, at the time of PEG insertion, a dual-lumen central line was placed and provided reliable access for drugs and blood sampling for the following week.

Postoperative care {#Sec4}
------------------

To reduce morbidity and mortality, and to improve welfare, we developed peri-operative care protocols, including high dependency care \[[@CR23]\]. Novel airway management methods, including a T-tube tracheostomy device (patent pending) and pain scoring systems were developed and are reported separately \[[@CR23]\]. Dexamethasone (0.06 mg/kg) was administered intravenously during anaesthesia. Antibiotics and non-steroidal anti-inflammatory drugs were given post-operatively. Opiate analgesia was used. Details of drugs used are provided in Table [1](#Tab1){ref-type="table"}.Table 1Drugs, and their doses, used peri-operatively and during the transplant operationsDrugTypeDoseDurationSourceCefuroximeAntibiotic10 mg/kg, IV 8 hourly7 daysGSK, Uxbridge, UKMetronidazoleAntibiotic10 mg/kg, oral (via PEG) 12 hourly7 daysHawgreen, Hitchin, UKDexamaethasoneSteroid0.06 mg/kg, IVDuring anaesthesiaIntervet UK Ltd, Milton Keynes, Bucks UKMorphineAnalgesic0.2 mg/kg every 4 h initially, then titrated using the pain scale7 daysMartindale Pharmaceuticals Ltd, Romford, EssexKetoprofen (10%)Non-steroidal anti-inflammatory3 mg/kg7 daysMerial Animal Health, Harlow Essex UKOr meloxicam (20 mg/ml)0.4 mg/kg7 daysBoehringer Ingelheim Ltd, Bracknell, Berkshire, UK

Post-operative feeding used milk (Parnutts Foods Ltd., Lincolnshire, UK.). Basic metabolic requirements were calculated as 2.621 × weight (kg)^0.63^MJ/day \[[@CR24]\] and four times this amount fed to compensate for the increased metabolic rate associated with recovery.

Transplant experiments {#Sec5}
----------------------

Seventeen fully-MHC2-matched, non-immmunosuppressed transplants were performed using published techniques \[[@CR20], [@CR25]\]. In brief, donor larynges were isolated via midline incisions and perfused with ice-cold University of Wisconsin solution (Dupont, Newcastle, UK) until efflux ran clear. The time of retrieval was recorded for each operation. At induction and after perfusion, mucosal biopsies were taken. Removed organs were placed in bags of University of Wisconsin solution on ice. During this period of cold ischemia, which mimics the time that may be involved in transporting donated organs between hospitals, the operating theatre was prepared for the recipient. Following general anaesthesia and endotracheal intubation, larynges were removed from recipient pigs using small-field laryngectomy. Ventilation was swapped to a T-tube tracheotomy to facilitate anaesthesia, post-operative care and to stent the anastomosis. Implantation used side-side anastomoses of superior vena cava into recipient right jugular venous confluence and right innominate artery into recipient right common carotid. No attempt was made to repair nerves since the primary aim was to study/perfect the transplant surgery and no functional recovery would occur by 1 week in any case. We have described nerve repair elsewhere \[[@CR18], [@CR26]\]. Mucosal biopsies were taken on reperfusion, which marked the end of cold ischaemia.

Recipients were anaesthetised at 48 h and grafts inspected via a 0^0^ Hopkins rod telescopes (Karl Storz, Berkshire, UK). Biopsies and laser Doppler readings were taken*.* Recipients underwent a second endoscopy at 7 days, following which they were killed (barbiturate). Grafts were photographed and mucosa and muscle sampled.

Mucosal perfusion {#Sec6}
-----------------

In order to assess graft perfusion at the capillary level, important since major vessel patency may not correlate with peripheral perfusion in a denervated organ, mucosal blood flux was measured midway along the right false vocal cord using laser Doppler (Moor Instruments, Devon, UK) at 0 (donor prior to organ recovery), 2 and 7 days \[[@CR27]\]. After establishing a steady reading, 30 s recordings were made.

Functional results {#Sec7}
------------------

Our T-tube device permits airflow through both tracheotomy and larynx. At 1 week, following occlusion of the tracheotomy limb, the ability of the pigs to produce a grunt and flow of air through the nose was assessed. Videofluoroscopy at 1 week assessed swallowing.

Myology: immunofluorescence histochemistry {#Sec8}
------------------------------------------

OCT embedded frozen biopsies of laryngeal muscles were prepared as previously described \[[@CR18]\]. Briefly, frozen 15 μm transverse sections of posterior cricoarytenoid (PCA) muscle and thyroarytenoid (TA) muscles from control and transplant animals were incubated with primary monoclonal myosin heavy chain (MyHC) antibodies described for western blot analysis below, together with rabbit anti-laminin antibody (Sigma) to highlight individual muscle fibres. Primary antibody was detected using secondary antibodies coupled to CY3 or FITC, respectively, and the sections were then viewed using a fluorescence microscope (BX60; Olympus, Tokyo, Japan).

Myology: western blotting {#Sec9}
-------------------------

Sections of muscle were homogenised in lysis buffer containing 100 mM PIPES, 5 mM MgCl, 20% (v/v) glycerol, 0.5% (v/v) Triton X-100, 5 mM EGTA and protease inhibitors (Sigma, UK). Ten μg protein per sample was denatured at 95°C for 5 min and resolved at 120 V on 10% SDS--PAGE gels. Following transfer to nitrocellulose, membranes were blocked for 1 h in 5% (w/v) non-fat dry milk in TBS-Tween, and then incubated overnight at 4°C with either monoclonal fast WB-MHCf (Leica Biosystems, Newcastle, UK; 1:2,000) or slow WB-MHCs (Leica Biosystems; 1:1,000) or embryonic F1.652 MyHC (Alexis Corporation, Nottingham, UK; 1:50) antibodies. Following six 5-min TBS-Tween washes, membranes were incubated for 1 h with HRP-conjugated secondary antibodies (goat anti-mouse 1:1,000; Cell Signalling Technology, USA). Membranes were washed and treated with chemiluminescent substrate (Amersham, UK) for 1 min. The blots were then exposed (1--10 min) to light-sensitive film, scanned and analysed (Scion Image, Scion Corporation, Maryland, USA).

Statistical methods {#Sec10}
-------------------

Western blotting densitometry was analysed using Kruskal--Wallis 1-way ANOVA.

Laser-Doppler results were analysed using analysis of variance (SPSS 12).

Results {#Sec11}
=======

Transplant operations {#Sec12}
---------------------

Median time for recovery and implantation were 150 min (range 108--210; *n* = 17) and 240 min (165--480), respectively; median cold ischemia time was 340 min (300--540). There was no difference in recovery, cold ischemia or graft implantation time between successful and unsuccessful operations (Fig. [1](#Fig1){ref-type="fig"}). Iterative improvements in technique over the first few cases included changing to a dedicated T-tube tracheotomy device with inner tube, and displacing the tracheotomy away from the site of anastomosis to reduce venous compression.Fig. 1Mean time for recovery, implantation and cold ischaemia for successful and unsuccessful laryngeal transplants. Figure shows mean with 95% confidence limits. *Filled square* successful; *opened square* unsuccessful

Graft survival, animal mortality and morbidity {#Sec13}
----------------------------------------------

Nine grafts were viable, and one more was borderline viable, to the point of censoring. Thus, eight animals were killed prematurely due to graft failure. In addition, 2 more pigs were killed due to airway obstruction, despite having viable grafts. This problem was overcome by developing the dedicated tube above. Thus, 7/17 animals survived with viable grafts at 7 days (Table [2](#Tab2){ref-type="table"}).Table 2Graft survival, animal mortality and morbidityTotal number of experiments17Viable grafts9 or 10Recipient alive at 48 h13Recipient alive at 7 days7

In the eight experiments where graft failure occurred, this was apparent by 48 h. Venous obstruction caused four grafts to fail, a problem later avoided by altering the site of the tracheotomy; one failed to perfuse on table due to inadequate heparinization; two failed to perfuse for unknown reasons (Table [3](#Tab3){ref-type="table"}). The healthy grafts were deep pink though edematous at 48 h (Fig. [2](#Fig2){ref-type="fig"}a, b); the edema subsided by 7 days, leaving a paler graft with normal morphology (Fig. [2](#Fig2){ref-type="fig"}c, d). At euthanasia, edema remained in the muscular compartment in two pigs (Fig. [2](#Fig2){ref-type="fig"}e, f).Table 3Causes of premature deathCauseNumberSolutionViable graftBlocked tracheostomy tube1Developed special T-tube, and protocol for airway cleaningLost tracheostomy tube1Other airway problems1Non-viable graftVenous occlusion4Enlist help of vascular surgeon, displace the tracheotomy away from the site of anastomosis to reduce venous compressionHeparinisation1Ensure dose correctly weight adjustedProlapsing fat/debris airway problems/?dead graft2Total10 Fig. 2Endoscopic appearance of (**a**), (**b**) laryngeal transplants at 48 h and (**c**), (**d**) at 7 days. At 48 h, the larynx is highly oedematous, whilst a patent lumen and visible vocal cords reappear by 1 week. Revascularised laryngeal graft 1 week after transplantation: (*white arrow* vascular pedicle; *black arrow* vocal cords) on removal (**e**) and sagittally split posteriorly (*arrow* healed tracheal anastomosis) (**f**)

Surviving animals were healthy at 1 week, exhibited normal social behaviour with care staff and experienced negligible weight loss (0.2 kg, range 1- gain 0.5). Minor complications encountered were wound infection (one) and wound dehiscence (two). These were easily managed with local measures.

Mucosal perfusion {#Sec14}
-----------------

Laser Doppler flux at the initial measurement was 171 arbitary units (AU) (range 69--418), there was a small increase at 48 h to 199 AU (range 48--386) and a small decrease at 7 days to 156 AU (56--247). There was no statistical difference in initial laser Doppler flux between successful and unsuccessful experiments (Fig. [3](#Fig3){ref-type="fig"}). Laser Doppler measurements were a useful means of confirming graft failure, with all ischemic larynges exhibiting readings of 50 arbitrary units or less. These values were not included in the analysis.Fig. 3**a** Laser Doppler flux recordings from a normal larynx (*top*), a successful graft (*middle*, mean flow 200 arbitrary units) and one which subsequently failed (*bottom*, mean \< 50). **b***Blue dye* injection into pedicle shows distribution of blood supply to all parts of the larynx. The supraglottis seemed relatively less well perfused, which may contribute to the observed lack of leukocyte changes in this sub-site. **c** Laser Doppler fluxmetry (mean ± 95% confidence limits, arbitrary units) of pig laryngeal graft mucosal blood flux at 0 (donor), 2 and 7 days post- transplantation. *Filled square* successful; *opened square* unsuccessful

Functional results {#Sec15}
------------------

In all seven pigs surviving with healthy grafts to 1 week, occlusion of the vertical limb of the T-tube resulted in passage of some air through the larynx. Audible grunts ('phonation') were produced by five recipient pigs. In no case, however, was airflow sufficient to support nasal breathing at 1 week. Four animals co-operated with videofluoroscopy: three swallowed freely without laryngeal penetration, aspiration or fistula (Fig. [4](#Fig4){ref-type="fig"}). One pig experienced minor aspiration which cleared on coughing.Fig. 4Barium swallow 1 week post-laryngeal transplantation in a pig. *White arrow* indicates *t*-tube tracheostomy within the transplanted subglottis. *Black arrows* show normal swallowing of contrast. There is no aspiration seen

Myology {#Sec16}
-------

Control muscle sections of posterior cricoarytenoid (PCA; Fig. [5](#Fig5){ref-type="fig"}a) and thyroarytenoid (TA; Fig. [5](#Fig5){ref-type="fig"}b) showed large-diameter fibres mainly positive for fast-type myosin heavy chain (MyHC). There was no expression of embryonic MyHC. However, samples retrieved at 7 days showed large reductions in fibre size, mosaic architecture and immuno-positivity for fast and slow type MyHC (Fig. [5](#Fig5){ref-type="fig"}a, b). Embryonic MyHC was expressed in some muscle fibres. Western blotting showed a significant reduction in levels of fast and slow MyHC in transplant muscles. Embryonic MyHC was expressed only in transplanted muscle (Fig. [6](#Fig6){ref-type="fig"}).Fig. 5Morphology of laryngeal muscle fibres. **a** Posterior cricoarytenoid (PCA) muscle. Transverse sections of control PCA (*top row*) and transplant PCA (*bottom row*) muscles stained with laminin antibody (*green*) and either fast type, slow type or embryonic MyHC protein antibody (*red*). **b** Thyroarytenoid (TA) muscle. Transverse sections of control TA (*top row*) and transplant TA (*bottom row*) muscles stained with laminin antibody (*green*) and either fast type, slow type or embryonic MyHC protein antibody (*red*) Fig. 6Changes in myosin heavy chain protein expression in transplanted muscle. **a** Western blots of lysates were prepared from the PCA and TA muscles from control animals (con) and transplanted (trans) muscle 7 days following surgery. Samples were electrophoresed and transferred to nitrocellulose membranes as described in "[Materials and methods](#Sec2){ref-type="sec"}". Membranes were probed with antibodies directed against fast, slow, or embryonic type MyHC protein. **b** Graphs show densitometry data as mean ± SEM values (*n* = 5 animals) \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001 significantly different when transplant muscle is compared with control muscle

Discussion {#Sec17}
==========

This is the first comprehensive description of the performance, management and early outcomes of laryngeal transplantation in a large animal and provides valuable preclinical data and experience for human trials. Following incremental technical modifications (dedicated T-tube, improved vascular technique, used of PEG tube and central line) good graft and pig survival were achieved in this valuable but labour-intensive model. Mucosal perfusion was sustained and normal by 1 week in surviving animals. Mucosal oedema was transient, leading to some airway patency and normal swallowing at 1 week. Laryngeal muscle morphology and phenotype altered significantly, consistent with denervation-induced atrophy. These data provide important baseline observations for further interventional studies, including unmatched grafts, long-term survival studies and studies of reinnervation.

Graft survival and function {#Sec18}
---------------------------

Operating times compared favourably with those for other complex grafts \[[@CR28], [@CR29]\]. High morbidity (\>50%) is common in experimental work involving major surgery in pigs. Nevertheless, incremental improvements in peri-operative care and operating technique during the series culminated in 100% peri-operative survival of the final 12 recipients.

We would hope that any future animal or human trial would have better survival rates. The improvements in surgical technique, such as placement of the graft, would be applied. Human patients would understand the surgical procedure and be more likely to comply with requests; for example, to keep still. In animal trials ethical considerations and licensing rules prevent any further intervention, whereas in a human if it were apparent that the graft had failed the graft could be removed.

The combination of videofluoroscopy, endoscopy, laser Doppler and measurement of airflow through the T-tube gave us confidence that the viable grafts were functional. In general the graft was not oedematous after 1 week; therefore, we think it unlikely that swallowing without aspiration was due to oedema at the superior part of the larynx. The mucosa of one graft remained oedematous at 1 week. The one reported human laryngeal graft exhibited initial oedema which subsided sufficiently to permit speech by 1 week \[[@CR6]\], as observed in the surviving pig larynges here. This oedema may represent part of the normal range of responses, or a response to minor antigen mismatches. However, our detailed immunological studies (presented in a separate paper) found no evidence to support the latter.

Mucosal perfusion {#Sec19}
-----------------

We have previously validated the use of laser Doppler fluxmetry as a measure of laryngeal mucosal blood flux in man and pig \[[@CR27]\]. Although laser Doppler measurements failed to predict success and failure in the present study, we found them useful in making decisions about the viability of grafts in the early post-operative period and may have clinical utility in this role; further studies would be required.

Myology {#Sec20}
-------

In two of five grafts for which detailed studies were performed, transplanted muscle was macroscopically identical to control muscle taken from the recipient's larynx prior to implantation. In other samples, breakdown of muscle structure, reductions in muscle fibre size and changes in phenotype were apparent, despite no significant changes in appearance or immunohistology of the mucosal compartment in the same larynges. This is most likely to be a consequence of denervation-induced atrophy. In a previous study on primate laryngeal muscles it was shown that denervation produced shrinkage of fast-type fibres within 2 weeks (particularly in the thyroarytenoid) and after 8 weeks all laryngeal muscles showed significant fibrosis \[[@CR30]\]. Similarly, in a rat model of recurrent laryngeal nerve transection there was an approximate 40% decrease in muscle fibre size and almost complete loss of synaptophysin-positive nerve terminals \[[@CR31]\] 2 weeks after denervation. Even as early as 7 days, denervation induces a significant reduction in muscle weight (which recovers upon reinnervation) and decreased fibre size in rat laryngeal muscles, with a large reduction in type IIB myosin heavy chain protein \[[@CR32]\]. This is consistent with our results showing a significant fall in fast-type MyHC protein levels; we have previously shown that type IIB MyHC predominates in pig laryngeal muscle \[[@CR18]\]. One study \[[@CR33]\] suggests slow type I MyHC is relatively unaffected by denervation, but another indicates that over a longer time-course there is a progressive reduction in expression \[[@CR34]\]. We also observed a "reactivation" of embryonic myosin heavy chain protein in transplanted muscles. This suggests to us that the atrophic changes occurring as a result of denervation can trigger a regenerative response mimicking the developmental processes of muscle formation \[[@CR35]\]. Indeed, recent studies indicate that compared with limb muscles, laryngeal muscle has an enhanced ability to respond to denervation as the result of a robust addition of myonuclei and myofibre remodelling due to intrinsic activation of muscle satellite cells \[[@CR36], [@CR37]\]. Thus, further studies are warranted to determine how functional reinnervation might be achieved following laryngeal transplantation. Lack of sensory innervation at 1 week was probably the cause of the minor aspiration noted in one animal, though its absence in the other four undergoing videofluoroscopy was encouraging.

Conclusion {#Sec21}
==========

This is the first detailed study of the acute vascular and myologic outcomes of laryngeal transplantation in a preclinical model. At 1 week, laryngeal transplants between pigs fully matched at the MHC2 loci are characterised by good function as measured by swallowing and 'phonation'. Laryngeal muscle displays signs of denervation induced atrophy, but the "reactivation" of embryonic MyHC is encouraging, suggesting that the muscle can actively mount a regenerative response after transplantation. The knowledge and skills we have gained from this 1-week study would permit us to progress, subject to licensing and ethical approval, with more confidence to longer term studies, in which the function of the graft can be robustly tested over several weeks or months. These studies provide a firm scientific basis on which to interpret the response to allografting in this robust pre-clinical model.

This study also provides some evidence and in vivo experience and training which would support subsequent clinical trials.
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